# DECNUPAZ

NDC: 0074-0282
Generic name: pivekimab sunirine-pvzy
Labeler / Manufacturer: AbbVie Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20260527

FDA application: BLA761460

## Active ingredients

- PIVEKIMAB SUNIRINE: 2 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0074-0282"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0074-0282
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=508b6ff8-601d-4901-a7a5-816141134054